BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4361626)

  • 1. [In-vivo effectivity of heterologous rabbit antisera against mouse leukemias].
    Milleck J; Pasternak G
    Arch Geschwulstforsch; 1973; 42(3):192-7. PubMed ID: 4361626
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the effectivity in vitro of heterologous rabbit antisera against mouse leukemia cells (author's transl)].
    Milleck J
    Arch Geschwulstforsch; 1973; 42(4):274-84. PubMed ID: 4138846
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo activities of heterologous antisera against mouse leukemias.
    Milleck J; Pasternak G
    Medicina (B Aires); 1976; 36(5):457-62. PubMed ID: 1004205
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined chemoimmunostimulation therapy against murine leukemia.
    Pearson JW; Pearson GR; Gibson WT; Chermann JC; Chirigos MA
    Cancer Res; 1972 May; 32(5):904-7. PubMed ID: 4552917
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterologous antiserum to chemically induced rat non-T, non-B leukemia and its application to characterization of rat leukemias.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 Feb; 41(2):708-12. PubMed ID: 6969631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppression by 334C murine leukemia virus: viral specificity and the activation of immunosuppressive effects during cloned viral leukemogenesis.
    Robinson MK; Manly KF; Evans MJ
    J Immunol; 1980 Mar; 124(3):1022-7. PubMed ID: 6244346
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular antigen of Friend virus-induced leukemias.
    Steeves RA
    Cancer Res; 1968 Feb; 28(2):338-42. PubMed ID: 5644179
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of the spleen in the pathogenesis of murine virus induced leukemias].
    Fey F
    Z Gesamte Inn Med; 1969 Aug; 24(16):511-3. PubMed ID: 4313553
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative importance of viral and neoantigens in cytotoxic reaction against murine leukaemia cells.
    Cohen MH; Sibal LR; Fink MA
    Immunology; 1974 Jan; 26(1):37-48. PubMed ID: 4367312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of N-nitrosobutylurea and azathioprine in induction of leukemia in C57BL mice.
    Imamura N; Nakano M; Kawase A; Kawamura Y; Yokoro K
    Gan; 1973 Oct; 64(5):493-8. PubMed ID: 4588868
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological analysis of N-nitrosourea-induced rat leukemia and experimental trials for therapy of human leukemia.
    Imamura N; Okada K
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1307-13. PubMed ID: 7168310
    [No Abstract]   [Full Text] [Related]  

  • 16. The activity of tolerant antileukemia sera. II. In vitro activity against normal tissue.
    Levi E; Zerubavel R
    Cancer Res; 1966 Apr; 26(4):668-72. PubMed ID: 5934899
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of the immune response to transplantation antigens. II. The effects of heterologous antisera on the growth of tumour allografts in mice.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):461-7. PubMed ID: 4468850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study by the agar gel-precipitation method of specific antigens in organs of mice and rats with Mazurenko viral leukemia.
    Shershul'skaya LV; Ievleva ES
    Fed Proc Transl Suppl; 1965; 24(6):1067-9. PubMed ID: 4284850
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralization of sublines of a mouse leukemia virus with murine antibody, as measured by the spleen focus assay.
    Sinkovics JG; Pienta RJ; Fiorentino M; Bertin BA
    Cancer Res; 1967 Jan; 27(1):88-94. PubMed ID: 6020368
    [No Abstract]   [Full Text] [Related]  

  • 20. Theta antigen in N-nitrosobutylurea leukemogenesis of the mouse.
    Hiai H; Shisa H; Matsudaira Y; Nishizuka Y
    Gan; 1973 Apr; 64(2):197-201. PubMed ID: 4723516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.